Brukinsa for Adult Patients with CLL/SLL
Loading Map....
Join us for an informative case-based discussion on the use of BRUKINSA® for the treatment of adult patients with chronic lymphocytic leukemia/small
lymphocytic lymphoma (CLL/SLL). The discussion will include the results from the latest BRUKINSA clinical trials as well as information on dosing &
administration, management of treatment-emergent adverse events, and patient support.
Healthcare professionals including PAs, NPs, and RNs in Hematology and Oncology are encouraged to participate in this interactive dialogue.
Speaker:
Rhonda Hewitt, APRN
Hematology Nurse Practitioner (APP IV)
Stanford Health Care
Palo Alto, CA